PharmaShots | Incisive News in 3 Shots

Subscribe Now

NeoImmuneTech

NeoImmuneTech’s Efineptakin Alfa (NT-I7) Receives the EMA’s Orphan Drug Designation to Treat Acute Radiation Syndrome

NeoImmuneTech’s Efineptakin Alfa (NT-I7) Receives the EMA’s Orphan Drug Designation to Treat Acute Radiation Syndrome

June 5, 2024

NeoImmuneTech’s NT-I7 (efineptakin alfa) Receives the US FDA Orphan Drug Designation for the Treatment of Glioblastoma Multiforme

NeoImmuneTech’s NT-I7 (efineptakin alfa) Receives the US FDA Orphan Drug Designation for the Treatment of Glioblastoma Multiforme

July 13, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us